Similar articles for PMID: 30937887

Year	Number of Results
2004	1
2011	1
2012	1
2013	4
2014	1
2015	4
2016	9
2017	19
2018	32
2019	29
2020	12
2021	8
2022	8
2023	4
2024	0

1

Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?

Sharma A, Buschmann MM, Gilbert JA. Sharma A, et al. Clin Pharmacol Ther. 2019 Aug;106(2):317-328. doi: 10.1002/cpt.1437. Epub 2019 May 7. Clin Pharmacol Ther. 2019. PMID: 30937887 Review.

2

Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.

Aziz RK, Hegazy SM, Yasser R, Rizkallah MR, ElRakaiby MT. Aziz RK, et al. Expert Opin Drug Metab Toxicol. 2018 Oct;14(10):1043-1055. doi: 10.1080/17425255.2018.1530216. Epub 2018 Oct 9. Expert Opin Drug Metab Toxicol. 2018. PMID: 30269615 Review.

3

Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine.

Hassan R, Allali I, Agamah FE, Elsheikh SSM, Thomford NE, Dandara C, Chimusa ER. Hassan R, et al. Brief Bioinform. 2021 Jul 20;22(4):bbaa292. doi: 10.1093/bib/bbaa292. Brief Bioinform. 2021. PMID: 33253350 Review.

4

Harnessing the Microbiome to Improve Drug Therapy.

Kelly L. Kelly L. Clin Pharmacol Ther. 2019 Aug;106(2):287-289. doi: 10.1002/cpt.1510. Clin Pharmacol Ther. 2019. PMID: 31355459 No abstract available.

5

Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity.

Li H, Jia W. Li H, et al. Clin Pharmacol Ther. 2013 Nov;94(5):574-81. doi: 10.1038/clpt.2013.157. Epub 2013 Aug 9. Clin Pharmacol Ther. 2013. PMID: 23933971 Review.

6

Pharmacomicrobiomics: a novel route towards personalized medicine?

Doestzada M, Vila AV, Zhernakova A, Koonen DPY, Weersma RK, Touw DJ, Kuipers F, Wijmenga C, Fu J. Doestzada M, et al. Protein Cell. 2018 May;9(5):432-445. doi: 10.1007/s13238-018-0547-2. Epub 2018 Apr 28. Protein Cell. 2018. PMID: 29705929 Free PMC article. Review.

7

Systems biology perspective for studying the gut microbiota in human physiology and liver diseases.

Altay O, Nielsen J, Uhlen M, Boren J, Mardinoglu A. Altay O, et al. EBioMedicine. 2019 Nov;49:364-373. doi: 10.1016/j.ebiom.2019.09.057. Epub 2019 Oct 18. EBioMedicine. 2019. PMID: 31636011 Free PMC article. Review.

8

Pharmacomicrobiomics informs clinical pharmacogenomics.

Katsila T, Balasopoulou A, Tsagaraki I, Patrinos GP. Katsila T, et al. Pharmacogenomics. 2019 Jul;20(10):731-739. doi: 10.2217/pgs-2019-0027. Epub 2019 Aug 1. Pharmacogenomics. 2019. PMID: 31368841

9

Interaction between drugs and the gut microbiome.

Weersma RK, Zhernakova A, Fu J. Weersma RK, et al. Gut. 2020 Aug;69(8):1510-1519. doi: 10.1136/gutjnl-2019-320204. Epub 2020 May 14. Gut. 2020. PMID: 32409589 Free PMC article. Review.

10

Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes.

Saad R, Rizkallah MR, Aziz RK. Saad R, et al. Gut Pathog. 2012 Nov 30;4(1):16. doi: 10.1186/1757-4749-4-16. Gut Pathog. 2012. PMID: 23194438 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year